Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Cboe Global Markets, Inc.CBOE · Entity 3134 | Director | May 14, 2026 | May 18, 2026 |
| EQUIFAX INCEFX · Entity 3235 | EVP, Chief Product Officer | February 25, 2026 | February 27, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Cboe Global Markets, Inc.
Report date May 14, 2026 · Filed May 18, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 2,441 |
Reported balance
After 2026-05-14 transaction · row 1
1 source rowRow 1 · 2026-05-14 · Grant · Acquired 530 · Balance 2,441 F1: Represents a restricted stock unit award granted under the Company's Third Amended and Restated Long-Term Incentive Plan, which meets the requirements of Rule 16b-3. Each restricted stock unit represents a contingent right to receive one share of Cboe Global Markets, Inc. common stock that will vest on May 14, 2027, provided that the filing person has remained in service continuously through such date. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents a restricted stock unit award granted under the Company's Third Amended and Restated Long-Term Incentive Plan, which meets the requirements of Rule 16b-3. Each restricted stock unit represents a contingent right to receive one share of Cboe Global Markets, Inc. common stock that will vest on May 14, 2027, provided that the filing person has remained in service continuously through such date.
EQUIFAX INC
Report date February 25, 2026 · Filed February 27, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 13,318 |
Reported balance
After 2026-02-25 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-02-25 · Grant · Acquired 2,695 · Balance 13,318 F1: Annual equity grant pursuant to the Company's long-term incentive plan. The award of restricted stock units vests 100% on February 25, 2029. F2: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. |
Filing footnotes · ownership attribution and instrument terms
F1: Annual equity grant pursuant to the Company's long-term incentive plan. The award of restricted stock units vests 100% on February 25, 2029.
F2: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 14, 2026 Filed May 18, 2026 15:30 UTC | Cboe Global Markets, Inc. CBOE · Entity 3134 | GrantCommon Stock | 530 | $0.00 | $0.00 |
DisclosureSEC source: 0002009173-26-000001 · form4-05182026_030509.xml · nonDerivative · entry 1 Mao Cecilia · CIK 0002009173 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,441 F1 · price: Represents a restricted stock unit award granted under the Company's Third Amended and Restated Long-Term Incentive Plan, which meets the requirements of Rule 16b-3. Each restricted stock unit represents a contingent right to receive one share of Cboe Global Markets, Inc. common stock that will vest on May 14, 2027, provided that the filing person has remained in service continuously through such date. Read SEC document |
| February 25, 2026 Filed Feb 27, 2026 21:14 UTC | EQUIFAX INC EFX · Entity 3235 | GrantCommon Stock | 2,695 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-002762 · doc4.xml · nonDerivative · entry 1 Mao Cecilia · CIK 0002009173 · EVP, Chief Product Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,318 F1 · security: Annual equity grant pursuant to the Company's long-term incentive plan. The award of restricted stock units vests 100% on February 25, 2029. F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| February 18, 2026 Filed Feb 19, 2026 21:22 UTC | EQUIFAX INC EFX · Entity 3235 | PurchaseCommon Stock | 2,400 | $193.72 | $464,928.00 |
DisclosureSEC source: 0001225208-26-002168 · doc4.xml · nonDerivative · entry 1 Mao Cecilia · CIK 0002009173 · EVP, Chief Product Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 10,623 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 11/18/2025. F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| February 10, 2026 Filed Feb 12, 2026 21:08 UTC | EQUIFAX INC EFX · Entity 3235 | Tax withholdingCommon Stock | 918 | $202.71 | $186,087.78 |
DisclosureSEC source: 0001225208-26-001776 · doc4.xml · nonDerivative · entry 2 Mao Cecilia · CIK 0002009173 · EVP, Chief Product Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,223 F1 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| February 10, 2026 Filed Feb 12, 2026 21:08 UTC | EQUIFAX INC EFX · Entity 3235 | GrantCommon Stock | 1,374 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-001776 · doc4.xml · nonDerivative · entry 1 Mao Cecilia · CIK 0002009173 · EVP, Chief Product Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,141 F1 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| May 06, 2025 Filed May 8, 2025 16:36 UTC | Cboe Global Markets, Inc. CBOE · Entity 3134 | GrantCommon Stock | 729 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-012365 · form4-05082025_080539.xml · nonDerivative · entry 1 Mao Cecilia · CIK 0002009173 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,911 F1 · price: Represents a restricted stock unit award granted under the Company's Third Amended and Restated Long-Term Incentive Plan, which meets the requirements of Rule 16b-3. Each restricted stock unit represents a contingent right to receive one share of Cboe Global Markets, Inc. common stock that will vest on May 6, 2026, provided that the filing person has remained in service continuously through such date. Read SEC document |
| February 11, 2025 Filed Feb 13, 2025 21:14 UTC | EQUIFAX INC EFX · Entity 3235 | Tax withholdingCommon Stock | 346 | $253.00 | $87,538.00 |
DisclosureSEC source: 0001225208-25-001654 · doc4.xml · nonDerivative · entry 2 Mao Cecilia · CIK 0002009173 · EVP, Chief Product Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,749 F1 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| February 11, 2025 Filed Feb 13, 2025 21:14 UTC | EQUIFAX INC EFX · Entity 3235 | GrantCommon Stock | 594 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-001654 · doc4.xml · nonDerivative · entry 1 Mao Cecilia · CIK 0002009173 · EVP, Chief Product Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,095 F1 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| February 10, 2025 Filed Feb 12, 2025 21:15 UTC | EQUIFAX INC EFX · Entity 3235 | GrantStock Option/Right to Buy · Derivative | 2,541 | $0.00 Strike: $252.90 | $0.00 |
DisclosureSEC source: 0001225208-25-001585 · doc4.xml · derivative · entry 2 Mao Cecilia · CIK 0002009173 · EVP, Chief Product Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,541 Underlying: Common Stock · 2,541 shares Expires 2035-02-10 F3 · derivative.exercise_date: Annual equity grant pursuant to the Company's long-term incentive plan. The option vests in three equal annual increments beginning February 10, 2026. Read SEC document |
| February 10, 2025 Filed Feb 12, 2025 21:15 UTC | EQUIFAX INC EFX · Entity 3235 | GrantCommon Stock | 791 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-001585 · doc4.xml · nonDerivative · entry 1 Mao Cecilia · CIK 0002009173 · EVP, Chief Product Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,501 F1 · security: Annual equity grant pursuant to the Company's long-term incentive plan. The award of restricted stock units vests 100% on February 10, 2028. F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| May 16, 2024 Filed May 20, 2024 16:37 UTC | Cboe Global Markets, Inc. CBOE · Entity 3134 | GrantCommon Stock | 937 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-013769 · form4-05202024_080549.xml · nonDerivative · entry 1 Mao Cecilia · CIK 0002009173 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,182 F1 · price: Represents a restricted stock unit award granted under the Company's Second Amended and Restated Long-Term Incentive Plan, which meets the requirements of Rule 16b-3. Each restricted stock unit represents a contingent right to receive one share of Cboe Global Markets, Inc. common stock that will vest on May 16, 2025, provided that the filing person has remained in service continuously through such date. Read SEC document |
| February 08, 2024 Filed Feb 12, 2024 17:05 UTC | Cboe Global Markets, Inc. CBOE · Entity 3134 | GrantCommon Stock | 245 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-003390 · form4-02122024_100220.xml · nonDerivative · entry 1 Mao Cecilia · CIK 0002009173 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 245 F1 · price: Represents a restricted stock unit award granted under the Company's Second Amended and Restated Long-Term Incentive Plan, which meets the requirements of Rule 16b-3. Each restricted stock unit represents a contingent right to receive one share of Cboe Global Markets, Inc. common stock that will vest on February 8, 2025, provided that the filing person has remained in service continuously through such date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.